諾發集團(1360.HK)跳水跌超80% 市值僅剩4億港元
格隆匯5月29日丨諾發集團(1360.HK)出現斷崖式下跌,一度由昨日收盤價1.37港元跌至盤中最低價0.226港元,現跌80.66%報0.265港元,創2015年以來新低,暫成交4459萬港元,最新總市值4.1億港元。公司是一家主要從事文化娛樂業務和展覽業務的投資控股公司。截至2019年12月31日,第一大股東和第二大股東分別持股11.23%和5.95%。目前淨賣出最多的券商是中財和寶通,分別為925萬股和677萬股,淨買入最多的是富途和越秀。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.